Success Story: Resuscitec

Executive Summary

💵 EUR 1.3 m project volume secured through non-dilutive research grant

🔐 Project: Prototypical construction of a compact and portable oxygenator with automated drug delivery for extracorporeal resuscitation measures (ECPR)

"We are very grateful that FUNDED has been so active in supporting us in obtaining the research allowance. We are also exploring other non-dilutive financing options with FUNDED."

Intrigued? Schedule a call now!

Interview with Jörg Ronde, CFO at Resuscitec

Background Information

Q: Can you provide a brief overview of your company and what you offer?

Jörg: Resuscitec is a Freiburg-based med-tech company on a mission to redefine resuscitation by increasing the chance of neurologically intact survival after cardiac arrest. Its CARL Therapy combines an extracorporeal circulation device, advanced monitoring, and real-time personalization of flow, blood composition, and temperature. Designed for use in both hospital and prehospital settings, CARL empowers medical teams to deliver precise, life-saving care where seconds matter.

Q: What specific product or service from FUNDED have you used?

Jörg: We partnered with FUNDED’s grant consulting team to successfully secure the Forschungszulage (R&D tax incentive). After receiving our positive funding decision, we implemented FundedOS to manage project documentation seamlessly and ensure full compliance with all funding requirements.

Experience with FUNDED

Q: What challenges were you facing before using FUNDED?

Jörg: Before partnering with FUNDED, navigating grant opportunities and managing the complex, time-intensive application process was a major challenge. FUNDED’s expertise simplified every step, from identifying the right programs to preparing detailed applications, making the entire process far more efficient and manageable.

Q: How did you discover FUNDED?

Jörg: We discovered FUNDED through trusted recommendations within our professional network. Their strong reputation for professionalism, expertise, and a proven track record in securing grants made the decision to collaborate straightforward.

Implementation and Use

Q: How was the onboarding and implementation process with FUNDED?

Jörg: FUNDED supported us seamlessly, helping us define a clear strategy and identify the projects with the strongest chances of success. Their structured approach guided us step by step through the application process, ensuring every stage was transparent and manageable. The consultants were approachable, responsive, and adept at turning complex topics into simple, actionable guidance.

Q: How are you using FUNDED’s product or service in your business?

Jörg: FUNDED supported us with expert advisory throughout the application process and complemented this with FundedOS, their end-to-end platform for documenting and managing the project. This combination of consulting and software made the process clear, efficient, and far less time-consuming for our team.

Results and Benefits

Q: What specific results or improvements have you seen since using FUNDED?

Jörg: Since partnering with FUNDED, we’ve received a positive funding decision and greatly reduced the internal effort needed for grant applications. Their support has given us the confidence to secure non-dilutive funding while keeping our focus on our core mission.

Q: What do you like most about FUNDED’s product or service?

Jörg: We deeply appreciate FUNDED’s proactive and client-oriented approach. By streamlining complex processes, providing clear communication at every stage, and delivering consistently high-quality outcomes.

Personal Insights

Q: Can you share a bit about your role and background?

Jörg: I’m the CFO and COO at Resuscitec GmbH.

Q: What excites you most about your industry and the future of your business?

Jörg: With our product, we are driving a shift in resuscitation and giving many people a second chance of life after cardiac arrest. Developing such a product scientifically and technologically, then getting it approved and into the market, requires a lot of time and money. In this respect, we are very grateful that FUNDED has been so active in supporting us in obtaining the research allowance. We are also exploring other non-dilutive financing options with FUNDED.